Viewing StudyNCT05722405



Ignite Creation Date: 2024-05-06 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 2:51 PM
Study NCT ID: NCT05722405
Status: RECRUITING
Last Update Posted: 2023-02-10
First Post: 2023-02-01

Brief Title: Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma
Sponsor: Second Affiliated Hospital School of Medicine Zhejiang University
Organization: Second Affiliated Hospital School of Medicine Zhejiang University

Organization Data

Organization: Second Affiliated Hospital School of Medicine Zhejiang University
Class: OTHER
Study ID: 2022-0215
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Second Affiliated Hospital School of Medicine Zhejiang University
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Affiliated Hospital of Jiaxing University OTHER
Huizhou Municipal Central Hospital OTHER
Lishui Country Peoples Hospital OTHER
Dongyang Peoples Hospital OTHER_GOV
Shangyu Peoples Hospital OTHER
Shaoxing Peoples Hospital OTHER
Shaoxing Second Hospital OTHER